Key genes in our signature, such as CLDN3, TMPRSS11D, SERPINB5, and FGFBP1, could be promising immunostains for the pathology-based differential diagnosis of NSCLC subtypes. The gene discussed is FGFBP1; the disease is non-small cell lung carcinoma.